These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17200113)

  • 1. Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4.
    Isin EM; Guengerich FP
    J Biol Chem; 2007 Mar; 282(9):6863-74. PubMed ID: 17200113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
    Isin EM; Guengerich FP
    J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
    Hosea NA; Miller GP; Guengerich FP
    Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.
    Roberts AG; Campbell AP; Atkins WM
    Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of cytochrome P450 3A4 inhibition by heterocyclic drugs defines a general sequential multistep binding process.
    Guengerich FP; McCarty KD; Chapman JG
    J Biol Chem; 2021; 296():100223. PubMed ID: 33449875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.
    Marsch GA; Carlson BT; Guengerich FP
    J Biomol Struct Dyn; 2018 Mar; 36(4):841-860. PubMed ID: 28278026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job's titration.
    Fernando H; Halpert JR; Davydov DR
    Biochemistry; 2006 Apr; 45(13):4199-209. PubMed ID: 16566594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochromic agents as tools for protein structure study: lapachenole is a photoaffinity ligand of cytochrome P450 3A4.
    Gartner CA; Wen B; Wan J; Becker RS; Jones G; Gygi SP; Nelson SD
    Biochemistry; 2005 Feb; 44(6):1846-55. PubMed ID: 15697210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-resolved fluorescence studies of heterotropic ligand binding to cytochrome P450 3A4.
    Lampe JN; Atkins WM
    Biochemistry; 2006 Oct; 45(40):12204-15. PubMed ID: 17014074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of cytochrome P450 3A4.
    Scott EE; Halpert JR
    Trends Biochem Sci; 2005 Jan; 30(1):5-7. PubMed ID: 15653318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
    Lin HL; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
    Locuson CW; Hutzler JM; Tracy TS
    Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cytochrome P450 3A4 by a pyrimidineimidazole: Evidence for complex heme interactions.
    Hutzler JM; Melton RJ; Rumsey JM; Schnute ME; Locuson CW; Wienkers LC
    Chem Res Toxicol; 2006 Dec; 19(12):1650-9. PubMed ID: 17173379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron transfer properties and catalytic competence of cytochrome b5 in the fusion protein Hmwb5-EGFP in reactions catalyzed by cytochrome P450 3A4.
    Yantsevich AV; Gilep AA; Usanov SA
    Biochemistry (Mosc); 2009 Aug; 74(8):862-73. PubMed ID: 19817686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding.
    Sohl CD; Isin EM; Eoff RL; Marsch GA; Stec DF; Guengerich FP
    J Biol Chem; 2008 Mar; 283(11):7293-308. PubMed ID: 18187423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
    Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps.
    Krauser JA; Guengerich FP
    J Biol Chem; 2005 May; 280(20):19496-506. PubMed ID: 15772082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.